Acting as a gateway to researchers carrying out world-leading clinical studies, the Clinical Trials Contracts team sets up contractual agreements with a range of companies on trials of new drugs and other cancer treatments – including at the Drug Development Unit at the ICR and The Royal Marsden, and via the ICR’s Clinical Trials and Statistics Unit (CTSU).
The experts in our team manage a wide range of contracts including drug supply agreements, site agreements, material transfer agreements, data transfer agreements, chief investigator agreements and amendments.
The team has strong relationships with a number of companies including AstraZeneca, Merck, Pfizer and Elekta.
Contact the Clinical Trials Contracts team